Optimizing Precision Medicine for Breast Cancer Brain Metastases with Functional Drug Response Assessment

The development of novel therapies for brain metastases is an unmet need. Brain metastases may have unique molecular features that could be explored as therapeutic targets. A better understanding of the drug sensitivity of live cells coupled to molecular analyses will lead to a rational prioritizati...

Descripción completa

Detalles Bibliográficos
Autores principales: Morikawa, Aki, Li, Jinju, Ulintz, Peter, Cheng, Xu, Apfel, Athena, Robinson, Dan, Hopkins, Alex, Kumar-Sinha, Chandan, Wu, Yi-Mi, Serhan, Habib, Verbal, Kait, Thomas, Dafydd, Hayes, Daniel F., Chinnaiyan, Arul M., Baladandayuthapani, Veerabhadran, Heth, Jason, Soellner, Matthew B., Merajver, Sofia D., Merrill, Nathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Association for Cancer Research 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284082/
https://www.ncbi.nlm.nih.gov/pubmed/37377606
http://dx.doi.org/10.1158/2767-9764.CRC-22-0492

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10284082/
https://www.ncbi.nlm.nih.gov/pubmed/37377606
http://dx.doi.org/10.1158/2767-9764.CRC-22-0492

Ejemplares similares